Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

AGX821 SARS-CoV-2 Spike (aa 251-660) Recombinant Antigen, 533

SARS-CoV-2 Spike (aa 251-660) Recombinant Antigen expressed in E. coli, Cat. No. AGX821 is for use in ELISA and Lateral Flow Assay.

AGX821
1 mg  
Purchase on Sigma-Aldrich

Overview

Replacement Information
Description
Catalogue NumberAGX821
DescriptionSARS-CoV-2 Spike (aa 251-660) Recombinant Antigen, 533
Alternate Names
  • COVID-19
  • 2019-nCoV
Background InformationCoronavirus disease 2019 (COVID-19) is an infectious disease caused by the virus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. A SARS-CoV-2 spike antigen can be used to support the detection of SARS-CoV-2 (COVID-19, 2019-nCoV).
References
Product Information
FormatPurified
PresentationPurified protein in 20mM Citrate buffer without preservatives, pH 9.5.
Quality LevelMQ100
Applications
ApplicationSARS-CoV-2 Spike (aa 251-660) Recombinant Antigen expressed in E. coli, Cat. No. AGX821 is for use in ELISA and Lateral Flow Assay.
Key Applications
  • ELISA
  • Immunodiffusion
Application NotesAlternative antigen recommendations are AGX822, AGX823, or AGX824
Biological Information
Immunogenfragment
CloneN/A
ConcentrationPlease refer to guidance on suggested starting dilutions and/or titers per application and sample type.
HostE. coli
Purification MethodColumn Purification
UniProt Number
Molecular Weight45 kDa
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsStable for 1 year at -20°C from date of receipt. Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles.
Packaging Information
Material Size1 mg
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Catalogue Number GTIN
AGX821 04061842605934